• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肺鳞状细胞癌中, 和其增强子与遗传起源相关。

Amplification of and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma.

机构信息

University of South Florida, USF Health Morsani College of Medicine, Tampa, FL.

Department of Pediatrics, University of Washington, Seattle, WA.

出版信息

JCO Precis Oncol. 2024 Oct;8:e2400223. doi: 10.1200/PO.24.00223. Epub 2024 Oct 24.

DOI:10.1200/PO.24.00223
PMID:39447097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520345/
Abstract

PURPOSE

In lung squamous cell carcinoma (LUSC), Black patients show significantly higher incidence and lower overall survival than White patients. Although socioeconomic factors likely contribute to this survival disparity, genomic factors have yet to be elucidated in LUSC.

METHODS

Using 416 LUSC tumor samples in the Cancer Genome Atlas (TCGA), we assessed genomic and transcriptomic profiles by ancestry. We replicated our analyses in pan-cancer data from TCGA, the American Association of Cancer Research (AACR) Genomics Evidence Neoplasia Information Exchange (GENIE), and Columbia University Medical Center.

RESULTS

We found increased amplification, LUSC-specific enhancer amplification, and chromosome arm 8q (chr8q) gain to be significantly associated with genetic AFR (African) ancestry in LUSC in TCGA. Furthermore, expression of target genes was significantly enriched in AFR samples. Local ancestry analysis identified correlation of chr8q gain with AFR ancestry at the locus in TCGA. We also found a significant correlation between chr8q and AFR ancestry in multiple cancer types and pan-cancer in TCGA. Similarly, in a pan-cancer subset of AACR GENIE data, we found a significant correlation between chr8q gain and race.

CONCLUSION

Together, our data suggest that ancestry may influence amplification of not only but also its enhancer in LUSC. They also suggest a role for genetic ancestry in chr8q aneuploidy in cancer. These studies further define and expand patients who may benefit from future anti- therapeutic approaches.

摘要

目的

在肺鳞状细胞癌(LUSC)中,黑人患者的发病率明显高于白人患者,总生存率低于白人患者。尽管社会经济因素可能导致这种生存差异,但 LUSC 的基因组因素尚未阐明。

方法

我们使用癌症基因组图谱(TCGA)中的 416 个 LUSC 肿瘤样本,通过祖先评估基因组和转录组谱。我们在 TCGA、美国癌症研究协会(AACR)基因组证据肿瘤信息交换(GENIE)和哥伦比亚大学医学中心的泛癌症数据中复制了我们的分析。

结果

我们发现,在 TCGA 的 LUSC 中,扩增、LUSC 特异性增强子扩增和染色体臂 8q(chr8q)获得与遗传 AFR(非洲)祖先显著相关。此外,在 AFR 样本中, 靶基因的表达明显富集。局部祖先分析确定了 TCGA 中 chr8q 获得与 位点的 AFR 祖先之间的相关性。我们还在 TCGA 的多个癌症类型和泛癌症中发现了 chr8q 与 AFR 祖先之间的显著相关性。同样,在 AACR GENIE 数据的泛癌症亚集中,我们发现 chr8q 增益与种族之间存在显著相关性。

结论

总之,我们的数据表明,祖先可能不仅影响 扩增,还可能影响其增强子在 LUSC 中的作用。它们还表明遗传祖先在癌症中 chr8q 非整倍体中的作用。这些研究进一步定义和扩大了可能受益于未来抗 治疗方法的患者群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/2aa2a8605b01/po-8-e2400223-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/0a366dff7c78/po-8-e2400223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/85e83dd07baf/po-8-e2400223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/7eed714f00d4/po-8-e2400223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/2aa2a8605b01/po-8-e2400223-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/0a366dff7c78/po-8-e2400223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/85e83dd07baf/po-8-e2400223-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/7eed714f00d4/po-8-e2400223-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed6/11520345/2aa2a8605b01/po-8-e2400223-g004.jpg

相似文献

1
Amplification of and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma.在肺鳞状细胞癌中, 和其增强子与遗传起源相关。
JCO Precis Oncol. 2024 Oct;8:e2400223. doi: 10.1200/PO.24.00223. Epub 2024 Oct 24.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Sun protection for preventing basal cell and squamous cell skin cancers.预防基底细胞癌和鳞状细胞皮肤癌的防晒措施。
Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2.
7
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
8
Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.人类非小细胞肺癌细胞系中细胞癌基因的不同表达模式。
J Cancer Res Clin Oncol. 1990;116(1):29-37. doi: 10.1007/BF01612637.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

引用本文的文献

1
Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy.上呼吸道和上消化道鳞状细胞癌:生物学、遗传学与治疗的统一视角
Cancer Cell. 2025 Feb 10;43(2):178-194. doi: 10.1016/j.ccell.2025.01.003.

本文引用的文献

1
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.非洲裔肿瘤测序揭示了常见癌症中具有临床意义的改变的差异。
Cancer Cell. 2023 Nov 13;41(11):1963-1971.e3. doi: 10.1016/j.ccell.2023.10.003. Epub 2023 Oct 26.
2
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.基于风险模型的肺癌筛查与美国的种族和民族差异
JAMA Oncol. 2023 Dec 1;9(12):1640-1648. doi: 10.1001/jamaoncol.2023.4447.
3
Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020.
美国 2018-2020 年按种族和民族划分的癌症死亡率。
J Natl Cancer Inst. 2023 Jul 6;115(7):822-830. doi: 10.1093/jnci/djad069.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry.非裔人群头颈部癌症的分子亚型。
Clin Cancer Res. 2023 Mar 1;29(5):910-920. doi: 10.1158/1078-0432.CCR-22-2258.
6
Annual report to the nation on the status of cancer, part 1: National cancer statistics.国家癌症报告:癌症统计数据 1. 全国癌症统计数据概览
Cancer. 2022 Dec 15;128(24):4251-4284. doi: 10.1002/cncr.34479. Epub 2022 Oct 27.
7
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors.FoundationOne®CDx 的临床和分析验证,一种用于实体瘤的全面基因组分析检测方法。
PLoS One. 2022 Mar 16;17(3):e0264138. doi: 10.1371/journal.pone.0264138. eCollection 2022.
8
Cancer statistics for African American/Black People 2022.2022 年非裔美国人/黑人癌症统计数据。
CA Cancer J Clin. 2022 May;72(3):202-229. doi: 10.3322/caac.21718. Epub 2022 Feb 10.
9
Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans.非裔美国人肿瘤中同源重组缺陷的发生率高于欧洲裔美国人。
Nat Cancer. 2020 Jan;1(1):112-121. doi: 10.1038/s43018-019-0009-7. Epub 2020 Jan 13.
10
Therapeutic targeting of "undruggable" MYC.靶向“不可成药” MYC 的治疗策略。
EBioMedicine. 2022 Jan;75:103756. doi: 10.1016/j.ebiom.2021.103756. Epub 2021 Dec 20.